282 related articles for article (PubMed ID: 16154219)
21. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease.
Veness MJ; Palme CE; Morgan GJ
Cancer; 2006 Jun; 106(11):2389-96. PubMed ID: 16649220
[TBL] [Abstract][Full Text] [Related]
22. Value of postoperative radiotherapy in patients with pathologic N1 neck disease.
Jäckel MC; Ambrosch P; Christiansen H; Martin A; Steiner W
Head Neck; 2008 Jul; 30(7):875-82. PubMed ID: 18302275
[TBL] [Abstract][Full Text] [Related]
23. Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy.
Dinshaw KA; Agarwal JP; Laskar SG; Gupta T; Shrivastava SK; Cruz AD
J Surg Oncol; 2005 Jul; 91(1):48-55. PubMed ID: 15999358
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.
Rades D; Fehlauer F; Wroblesky J; Albers D; Schild SE; Schmidt R
Oral Oncol; 2007 Jul; 43(6):535-43. PubMed ID: 17005437
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck.
Christiansen H; Hermann RM; Martin A; Florez R; Kahler E; Nitsche M; Hille A; Steiner W; Hess CF; Pradier O
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1067-74. PubMed ID: 16750331
[TBL] [Abstract][Full Text] [Related]
26. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT.
Studer G; Luetolf UM; Glanzmann C
Strahlenther Onkol; 2007 Aug; 183(8):417-23; discussion 424-5. PubMed ID: 17680220
[TBL] [Abstract][Full Text] [Related]
27. Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma.
Temam S; Koka V; Mamelle G; Julieron M; Carmantrant R; Marandas P; Janot F; Bourhis J; Luboinski B
Head Neck; 2005 Aug; 27(8):653-8. PubMed ID: 16035097
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
[TBL] [Abstract][Full Text] [Related]
29. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
30. Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients.
Beldì D; Jereczek-Fossa BA; D'Onofrio A; Gambaro G; Fiore MR; Pia F; Chiesa F; Orecchia R; Krengli M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1051-8. PubMed ID: 17716824
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
32. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
33. Postoperative complications after en bloc salvage surgery for head and neck cancer.
Agra IM; Carvalho AL; Pontes E; Campos OD; Ulbrich FS; Magrin J; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1317-21. PubMed ID: 14676158
[TBL] [Abstract][Full Text] [Related]
34. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
[TBL] [Abstract][Full Text] [Related]
35. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
37. Initial clinical experience with helical tomotherapy for head and neck cancer.
Chen AM; Jennelle RL; Sreeraman R; Yang CC; Liu T; Vijayakumar S; Purdy JA
Head Neck; 2009 Dec; 31(12):1571-8. PubMed ID: 19405087
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma.
Daly ME; Lieskovsky Y; Pawlicki T; Yau J; Pinto H; Kaplan M; Fee WE; Koong A; Goffinet DR; Xing L; Le QT
Head Neck; 2007 Mar; 29(3):211-20. PubMed ID: 17111429
[TBL] [Abstract][Full Text] [Related]
40. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]